Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
Go back to Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches| AmerAlia, Inc. (NYSE: ALA) | Delayed: 14.50 -0.56 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.06 | 52 Week High | $0.75 | |||
| Open | $15.41 | 52 Week Low | $0.75 | |||
| Day High | $15.41 | P/E | N/A | |||
| Day Low | $14.50 | EPS | $0.00 | |||
| Volume | 2,276 | |||||
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 229.29 +10.59 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.70 | 52 Week High | $89.18 | |||
| Open | $234.07 | 52 Week Low | $65.70 | |||
| Day High | $238.85 | P/E | 106.65 | |||
| Day Low | $224.28 | EPS | $2.15 | |||
| Volume | 1,075,121 | |||||
